全文获取类型
收费全文 | 1326篇 |
免费 | 171篇 |
出版年
2022年 | 7篇 |
2021年 | 14篇 |
2020年 | 9篇 |
2018年 | 13篇 |
2017年 | 9篇 |
2016年 | 15篇 |
2015年 | 42篇 |
2014年 | 56篇 |
2013年 | 68篇 |
2012年 | 75篇 |
2011年 | 65篇 |
2010年 | 48篇 |
2009年 | 31篇 |
2008年 | 59篇 |
2007年 | 52篇 |
2006年 | 52篇 |
2005年 | 56篇 |
2004年 | 46篇 |
2003年 | 52篇 |
2002年 | 34篇 |
2001年 | 36篇 |
2000年 | 44篇 |
1999年 | 43篇 |
1998年 | 22篇 |
1997年 | 21篇 |
1996年 | 28篇 |
1995年 | 18篇 |
1994年 | 14篇 |
1993年 | 12篇 |
1992年 | 34篇 |
1991年 | 37篇 |
1990年 | 44篇 |
1989年 | 24篇 |
1988年 | 32篇 |
1987年 | 25篇 |
1986年 | 28篇 |
1985年 | 17篇 |
1984年 | 15篇 |
1983年 | 14篇 |
1982年 | 14篇 |
1981年 | 10篇 |
1980年 | 10篇 |
1979年 | 7篇 |
1978年 | 10篇 |
1975年 | 8篇 |
1974年 | 14篇 |
1973年 | 13篇 |
1972年 | 12篇 |
1970年 | 7篇 |
1969年 | 7篇 |
排序方式: 共有1497条查询结果,搜索用时 15 毫秒
71.
Two enteric pathogens, Campylobacter jejuni and Yersinia enterocolitica serogroup O:3, together with Escherichia coli, were investigated for susceptibility to UV radiation at 254 nm. The UV dose required for a 3-log reduction (99.9% inactivation) of C. jejuni, Y. enterocolitica, and E. coli was 1.8, 2.7, and 5.0 mWs/cm2, respectively. Using E. coli as the basis for comparison, it appears that C. jejuni and Y. enterocolitica serogroup O:3 are more sensitive to UV than many of the pathogens associated with waterborne disease outbreaks and can be easily inactivated in most commercially available UV reactors. No association was found between the sensitivity of Y. enterocolitica to UV and the presence of a 40- to 50-megadalton virulence plasmid. 相似文献
72.
Protein synthesis and formation of guanosinetetraphosphate 总被引:3,自引:0,他引:3
73.
By means of autoradiography a high and selective accumulation was observed in the lung alveolar region of C57Bl mice injected with o,p'-[14C]DDD. Exhaustive extraction of lung tissue showed that a large fraction of the radioactivity was covalently bound to protein. Covalent binding in liver was 20-30 times lower and represented a smaller fraction of the total radioactivity present in this tissue. Formation of a cytochrome P-450 catalysed reactive metabolite in lung and liver was indicated by a decreased covalent binding in these tissues in mice pretreated with metyrapone. Both beta-naphthoflavone (beta NF) and phenobarbital (PB) pretreatment decreased binding of o,p'-DDD in lung tissue, while binding in the liver was induced by PB but remained unaffected by beta NF. Pretreatment with high doses of o,p'-DDD and p,p'-DDT gave a significantly decreased binding of o,p'-[14C]DDD in lung, whereas binding in liver remained unchanged. Conjugation with glutathione does not appear to be a major inactivation pathway for the reactive lung metabolite, since a high dose of o,p'-DDD did not deplete non-protein thiols (NPSH) in lung tissue. Pretreatment with o,p'-DDD decreased the N-demethylation of [dimethyl-14C]aminopyrine in both lung and liver in a dose-dependent manner, suggesting that the drug-metabolizing enzyme system may be a target for o,p'-DDD in vivo. 相似文献
74.
75.
76.
W. Frommer L. Archer B. Boon G. Brunius C. H. Collins P. Crooy R. Donikian I. Economidis C. Frontali T. Gaal S. Hamp H. Haymerle P. Krämer H. Lagast H. M. L. Lelieveld M. Th. Logtenberg S. Lund J. L. Mahler F. Normand-Plessier F. Rudan R. Simon G. Tuijnenberg Muijs R. G. Werner 《Applied microbiology and biotechnology》1992,38(2):139-140
The Working Party on Safety in Biotechnology of the European Federation of Biotechnology has proposed a classification of microorganisms that cause diseases in plants. In this paper appropriate safety levels are proposed for these classes of microorganisms in order to ensure that research, development and industrial fermentation work with plant pathogens will limit the risk of outbreaks of diseases in crops that could result from work with such microorganisms when they are cultivated in laboratories, glasshouses and biotechnology installations.Co-opted: J. Dähne, J. Drozd, M. Lemattre, I. M. Smith , E. M. A. WaterschootA Report prepared by the Working Party on Safety in Biotechnology of the European Federation of Biotechnology (EFB)
相似文献
相似文献
77.
78.
79.
Brian Henderson Mario A. Fares Peter A. Lund 《Biological reviews of the Cambridge Philosophical Society》2013,88(4):955-987
Chaperonin 60 is the prototypic molecular chaperone, an essential protein in eukaryotes and prokaryotes, whose sequence conservation provides an excellent basis for phylogenetic analysis. Escherichia coli chaperonin 60 (GroEL), the prototype of this family of proteins, has an established oligomeric‐structure‐based folding mechanism and a defined population of folding partners. However, there is a growing number of examples of chaperonin 60 proteins whose crystal structures and oligomeric composition are at variance with GroEL, suggesting that additional complexities in the protein‐folding function of this protein should be expected. In addition, many organisms have multiple chaperonin 60 proteins, some of which have lost their protein‐folding ability. It is emerging that this highly conserved protein has evolved a bewildering variety of additional biological functions – known as moonlighting functions – both within the cell and in the extracellular milieu. Indeed, in some organisms, it is these moonlighting functions that have been left after the loss of the protein‐folding activity. This highlights the major paradox in the biology of chaperonin 60. This article reviews the relationship between the folding and non‐folding (moonlighting) activities of the chaperonin 60 family and discusses current knowledge on their molecular evolution focusing on protein domains involved in the non‐folding chaperonin functions in an attempt to understand the emerging biology of this evolutionarily ancient protein family. 相似文献
80.
Olatundun Williams Daniel Gbadero Grace Edowhorhu Ann Brearley Tina Slusher Troy C. Lund 《PloS one》2013,8(7)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzymopathy and in Sub-Saharan Africa, is a significant cause of infection- and drug-induced hemolysis and neonatal jaundice. Our goals were to determine the prevalence of G6PD deficiency among Nigerian children of different ethnic backgrounds and to identify predictors of G6PD deficiency by analyzing vital signs and hematocrit and by asking screening questions about symptoms of hemolysis. We studied 1,122 children (561 males and 561 females) aged 1 month to 15 years. The mean age was 7.4±3.2 years. Children of Yoruba ethnicity made up the largest group (77.5%) followed by those Igbo descent (10.6%) and those of Igede (10.2%) and Tiv (1.8%) ethnicity. G6PD status was determined using the fluorescent spot method. We found that the overall prevalence of G6PD deficiency was 15.3% (24.1% in males, 6.6% in females). Yoruba children had a higher prevalence (16.9%) than Igede (10.5%), Igbo (10.1%) and Tiv (5.0%) children. The odds of G6PD deficiency were 0.38 times as high in Igbo children compared to Yoruba children (p = 0.0500). The odds for Igede and Tiv children were not significantly different from Yoruba children (p = 0.7528 and 0.9789 respectively). Mean oxygen saturation, heart rate and hematocrit were not significantly different in G6PD deficient and G6PD sufficient children. The odds of being G6PD deficient were 2.1 times higher in children with scleral icterus than those without (p = 0.0351). In conclusion, we determined the prevalence of G6PD deficiency in Nigerian sub-populations. The odds of G6PD deficiency were decreased in Igbo children compared to Yoruba children. There was no association between vital parameters or hematocrit and G6PD deficiency. We found that a history of scleral icterus may increase the odds of G6PD deficiency, but we did not exclude other common causes of icterus such as sickle cell disease or malarial infection. 相似文献